To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
10 Current news of GBI Research
rss
Big Pharma Embraces Biologics
22-11-2012
Fast-evolving biopharmaceuticals will challenge synthetic market dominance in the global market for active pharmaceutical ingredients (APIs), states a new report by business intelligence providers GBI Research.The new report "Active Pharmaceutical Ingredients (APIs) Global Market to 2017 - ...
Biodefense: Anthrax and Smallpox at the Research Forefront
04-10-2012
As the potential threat of biological terrorist attacks continues to command the attention of governments around the globe, anthrax and smallpox remain amongst the most researched diseases in the biodefense industry, states a new report by GBI Research.The company’s latest study shows that ...
$800 Billion: The Amount US Healthcare Industry ‘Wasted’ in 2011
24-08-2012
Avoidable care, incompetent hospital management and administrations scams accounted for an astonishing $800-$900 billion in unnecessary healthcare expenditure in the US last year, according to the latest findings of business intelligence experts GBI Research. The new report,Pharmaceutical ...
HIV Generics Take Over the Antivirals Market
03-07-2012
Generics are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as a series of patent expiries will open opportunities for ambitious companies to seize huge revenue, according to a new report by healthcare experts GBI Research.The new report, ...
Are Biosimilars Too Expensive for Emerging Economies?
18-06-2012
The global market for biosimilar drugs is due to come under attack from popular generic drugs, as governments fight to control rising healthcare expenditure, according to healthcare experts GBI Research.The report "Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms ...
Medications Made Available to All: OTC Status Boosts Global Drug Sales
02-05-2012
The conversion of prescription drugs to over-the-counter (OTC) status is becoming a hit among major pharmaceutical companies in developing countries, who are eager to expand their target audience, according to a new report by healthcare intelligence company GBI Research.The new report, ...
Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
26-04-2012
Generic drugs are evolving and, at the same time, being outshone by their predecessors – super-powered pharmaceuticals developed through simplified development pathways – according to a new report by GBI Research.The new report indicates that the development of “supergenerics” is creating ...
Unhealthy Lifestyles Contribute to Boom in Cardiac Rhythm Management Market
11-04-2012
A hearty combination of technological leaps and unhealthy lifestyle choices are driving sales of the cardiac rhythm monitoring (CRM) devices, a new report by GBI Research has found. The new report, 'Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory ...
Cost of Antivirals for HIV/AIDS Set to Increase
11-04-2012
Antiviral drugs for HIV/AIDS patients will become more expensive as doctors embrace new, highly-priced combination treatments, according to a new report by pharmaceutical industry experts GBI Research.The new report, 'Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies ...
Diabetes Set to Become Biggest Killer in India, China and Brazil
26-03-2012
The emerging countries of India, Brazil and China are seeing swift increases in the prevalence of diabetes, as financial development is met by unhealthy lifestyle choices and subsequent chronic disease, according to a new report by business intelligence expert GBI Research.The new report ...
Page 1 From 1
Netmeeting
